vs

Side-by-side financial comparison of Millrose Properties, Inc. (MRP) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $189.5M, roughly 1.0× Millrose Properties, Inc.). Millrose Properties, Inc. runs the higher net margin — 64.5% vs 6.7%, a 57.8% gap on every dollar of revenue.

Millrose Properties, Inc. is a U.S.-based real estate enterprise primarily focused on the acquisition, ownership, operation, and management of income-generating multi-family residential assets. Its core markets span the U.S. Mid-Atlantic and Southeast regions, and it also offers professional property management services to select third-party property owners.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

MRP vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.0× larger
RGEN
$197.9M
$189.5M
MRP
Higher net margin
MRP
MRP
57.8% more per $
MRP
64.5%
6.7%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRP
MRP
RGEN
RGEN
Revenue
$189.5M
$197.9M
Net Profit
$122.2M
$13.3M
Gross Margin
52.5%
Operating Margin
84.8%
9.0%
Net Margin
64.5%
6.7%
Revenue YoY
13.6%
Net Profit YoY
285.8%
143.9%
EPS (diluted)
$0.74
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRP
MRP
RGEN
RGEN
Q4 25
$189.5M
$197.9M
Q3 25
$179.3M
$188.8M
Q2 25
$149.0M
$182.4M
Q1 25
$82.7M
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
MRP
MRP
RGEN
RGEN
Q4 25
$122.2M
$13.3M
Q3 25
$105.1M
$14.9M
Q2 25
$112.8M
$14.9M
Q1 25
$39.8M
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
MRP
MRP
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
MRP
MRP
RGEN
RGEN
Q4 25
84.8%
9.0%
Q3 25
85.3%
8.9%
Q2 25
85.1%
7.6%
Q1 25
55.2%
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
MRP
MRP
RGEN
RGEN
Q4 25
64.5%
6.7%
Q3 25
58.6%
7.9%
Q2 25
75.7%
8.2%
Q1 25
48.1%
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
MRP
MRP
RGEN
RGEN
Q4 25
$0.74
$0.24
Q3 25
$0.63
$0.26
Q2 25
$0.68
$0.26
Q1 25
$0.39
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRP
MRP
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$35.0M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$5.9B
$2.1B
Total Assets
$9.3B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRP
MRP
RGEN
RGEN
Q4 25
$35.0M
$767.6M
Q3 25
$242.6M
$748.7M
Q2 25
$66.6M
$708.9M
Q1 25
$89.5M
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
MRP
MRP
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MRP
MRP
RGEN
RGEN
Q4 25
$5.9B
$2.1B
Q3 25
$5.9B
$2.1B
Q2 25
$5.9B
$2.1B
Q1 25
$5.9B
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
MRP
MRP
RGEN
RGEN
Q4 25
$9.3B
$2.9B
Q3 25
$9.0B
$2.9B
Q2 25
$8.0B
$2.9B
Q1 25
$7.2B
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
MRP
MRP
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRP
MRP
RGEN
RGEN
Operating Cash FlowLast quarter
$3.7B
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
30.05×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRP
MRP
RGEN
RGEN
Q4 25
$3.7B
$25.7M
Q3 25
$123.1M
$48.1M
Q2 25
$109.1M
$28.6M
Q1 25
$21.3M
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
MRP
MRP
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
MRP
MRP
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
MRP
MRP
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
MRP
MRP
RGEN
RGEN
Q4 25
30.05×
1.93×
Q3 25
1.17×
3.23×
Q2 25
0.97×
1.92×
Q1 25
0.53×
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons